# Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)

> **NCT02504944** · PHASE2 · COMPLETED · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 98 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Propranolol 0.2% eye drops

## Key facts

- **NCT ID:** NCT02504944
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02504944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02504944, "Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02504944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*